A microdeletion in the ligand binding domain of human steroidogenic factor 1 causes XY sex reversal without adrenal insufficiency

被引:108
|
作者
Correa, RV
Domenice, S
Bingham, NC
Billerbeck, AEC
Rainey, WE
Parker, KL
Mendonca, BB
机构
[1] Univ Sao Paulo, Fac Med, Hosp Clin, Dev Endocrinol Unit, BR-05403900 Sao Paulo, Brazil
[2] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
[3] Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA
来源
关键词
D O I
10.1210/jc.2003-031240
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Steroidogenic factor 1 (SF-1) is an orphan nuclear receptor that plays key roles in endocrine development and function. Knockout mice lacking SF-1 have adrenal and gonadal agenesis, impaired gonadotropin expression, and structural abnormalities of the ventromedial hypothalamic nucleus. Previous studies have identified three human subjects with mutations in SF-1 causing adrenocortical insufficiency with varying degrees of gonadal dysfunction. We now describe a novel 8-bp microdeletion of SF-1, isolated from a 46, XY patient who presented with gonadal agenesis but normal adrenal function, which causes premature termination upstream of sequences encoding the activation function 2 domain. In cell transfection experiments, the mutated protein possessed no intrinsic transcriptional activity but rather inhibited the function of the wild-type protein in most cell types. To our knowledge, this is the first example of an apparent dominant-negative effect of a SF-1 mutation in humans. These findings, which define a SF-1 mutation that apparently differentially affects its transcriptional activity in vivo in the adrenal cortex and the gonads, may be relevant to the cohort of patients who present with 46, XY sex reversal but normal adrenal function.
引用
收藏
页码:1767 / 1772
页数:6
相关论文
共 31 条
  • [21] Screening for mutations in the steroidogenic acute regulatory protein and steroidogenic factor-1 genes, and in CYP11A and dosage-sensitive sex reversal-adrenal hypoplasia gene on the X chromosome, gene-1 (DAX-1), in hyperandrogenic hirsute women
    Calvo, RM
    Asunción, M
    Tellería, D
    Sancho, J
    San Millán, JL
    Escobar-Morreale, HF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1746 - 1749
  • [22] Characterization of ligand binding to human von Willebrand factor domain A1 by single residue charged-to-alanine scanning mutagenesis
    Matsushita, T
    Sadler, JE
    THROMBOSIS AND HAEMOSTASIS, 1997, : P1489 - P1489
  • [23] Structures of the human Pals1 PDZ domain with and without ligand suggest gated access of Crb to the PDZ peptide-binding groove
    Ivanova, Marina E.
    Fletcher, Georgina C.
    O'Reilly, Nicola
    Purkiss, Andrew G.
    Thompson, Barry J.
    McDonald, Neil Q.
    ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2015, 71 : 555 - 564
  • [24] Clinical case seminar - Homozygous mutation of P450 side-chain cleavage enzyme gene (CYP11A1) in 46, XY patient with adrenal insufficiency, complete sex reversal, and agenesis of corpus callosum
    al Kandari, Hessa
    Katsumata, Noriyuki
    Alexander, Suzan
    Rasoul, Majedah Abdul
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (08): : 2821 - 2826
  • [25] Over-expression and purification of isotopically labeled recombinant ligand-binding domain of orphan nuclear receptor human B1-binding factor/human liver receptor homologue 1 for NMR studies
    Chen, X
    Tong, XT
    Xie, YH
    Wang, Y
    Ma, JB
    Gao, DM
    Wu, HM
    Chen, HB
    PROTEIN EXPRESSION AND PURIFICATION, 2006, 45 (01) : 99 - 106
  • [26] Protein kinase A potentiates adrenal 4 binding protein/steroidogenic factor 1 transactivation by reintegrating the subcellular dynamic interactions of the nuclear receptor with its cofactors, general control nonderepressed-5/transformation/transcription domain-associated protein, and suppressor, dosage-sensitive sex reversal-1: A laser confocal imaging study in living KGN cells
    Fan, WQ
    Yanase, T
    Wu, Y
    Kawate, H
    Saitoh, M
    Oba, K
    Nomura, M
    Okabe, T
    Goto, K
    Yanagisawa, J
    Kato, S
    Takayanagi, R
    Nawata, H
    MOLECULAR ENDOCRINOLOGY, 2004, 18 (01) : 127 - 141
  • [27] Immunolocalization of nuclear transcription factors, DAX-1 and COUP-TF II, in the normal human ovary: Correlation with adrenal 4 binding protein/steroidogenic factor-1 immunolocalization during the menstrual cycle
    Sato, Y
    Suzuki, T
    Hidaka, K
    Sato, H
    Ito, K
    Ito, S
    Sasano, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07): : 3415 - 3420
  • [28] Identification of the ligand-binding domain of human vascular-endothelial-growth-factor receptor Flt-1 (vol 34, pg 199, 2001)
    Ma, L
    Wang, X
    Zhang, Z
    Zhou, X
    Chen, A
    Yao, L
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 2002, 35 : 221 - 221
  • [29] Synergistic activation of the human type II 3 beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase promoter by the transcription factor steroidogenic factor-1/adrenal 4-binding protein and phorbol ester
    LeersSucheta, S
    Morohashi, K
    Mason, JI
    Melner, MH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) : 7960 - 7967
  • [30] A G1127S change in calcium-binding epidermal growth factor-like domain 13 of human fibrillin-1 causes short range conformational effects
    Whiteman, P
    Smallridge, RS
    Knott, V
    Cordle, JJ
    Downing, AK
    Handford, PA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) : 17156 - 17162